NYSE:CTVAChemicals
The Bull Case For Corteva (CTVA) Could Change Following Q4 Loss, UBS Downgrade, And Planned Split
In early February 2026, Corteva, Inc. reported fourth-quarter 2025 results showing quarterly sales of US$3,910 million and a net loss of US$552 million, alongside full-year 2025 sales of US$17.40 billion and net income of US$1.09 billion, and issued 2026 operating EPS guidance of US$3.45–US$3.70 per share.
On the same day, UBS downgraded Corteva to a neutral stance as the company prepares to split its seed and crop protection businesses by early 2027, highlighting execution risks and higher...